Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $33.2800 (0.48%) ($32.8000 - $34.0000) on Mon. Jul. 18, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.65% (three month average) | RSI | 77 | Latest Price | $33.2800(0.48%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EYES advances 10.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(8%) UUP(6%) ICLN(5%) ARKG(4%) ARKK(4%) | Factors Impacting EYES price | EYES will decline at least -2.825% in a week (0% probabilities). BND(-7%) BNDX(-5%) XLU(-4%) XLP(-4%) VCSH(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.825% (StdDev 5.65%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
5 Day Moving Average | $33.18(0.3%) | 10 Day Moving Average | $31.91(4.29%) | 20 Day Moving Average | $30.26(9.98%) | To recent high | -28.9% | To recent low | 30.8% | Market Cap | $10.63b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |